Artificial Pancreas
Hybrid closed-loop system provides glycemic benefits, may be cost-effective in pregnancy
An advanced hybrid closed-loop insulin delivery system is safe to use for pregnant women with type 1 diabetes and may provide some glycemic benefits, especially during overnight hours, according to a presenter.
Automated insulin delivery may be ‘key first-line therapy’ for type 1 diabetes
Patients with type 1 diabetes initiating automated insulin delivery had a significantly lower HbA1c at 13 weeks than those receiving multiple daily insulin injections, according to a presenter.
Automated insulin delivery provides range of glycemic benefits in type 2 diabetes
Adults with insulin-treated type 2 diabetes had greater HbA1c reductions and larger improvement in time in range with use of an automated insulin delivery system compared with standard care, according to findings from a new trial.
Q&A: How adults with type 1 diabetes can become commercial airline pilots
Data from the Barbara Davis Center for Diabetes at University of Colorado show pilots with type 1 diabetes are not just thriving in the air, but also with their diabetes management.
Automated insulin delivery lowers HbA1c, improves time in range in type 2 diabetes
Adults with insulin-treated type 2 diabetes had a significant HbA1c decline at 13 weeks with use of the Omnipod 5 automated insulin delivery system, according to findings from the SECURE-T2D trial.
Although superior to other insulin therapies, hybrid closed-loop systems differ in efficacy
Hybrid closed-loop systems outperformed other types of subcutaneous insulin treatment for diabetes, but some systems were more efficient than others, according to results published in Diabetes/Metabolism Research and Reviews.
Q&A: Tips for navigating use of diabetes devices in schools
One of many challenges parents face when their child is diagnosed with diabetes is how the condition will be managed in school, particularly if the child is using a diabetes device.
Semaglutide improves glucose control in automated insulin delivery for type 1 diabetes
In a small study of patients with type 1 diabetes using an automated insulin delivery system, semaglutide improved glucose control vs. placebo, researchers reported at the European Association for the Study of Diabetes Annual Meeting.
Individualized settings can maximize benefits of automated insulin delivery in pregnancy
Pregnant women with diabetes can use automated insulin delivery systems with settings optimized to achieve tight glycemic targets, according to two speakers at the Association of Diabetes Care and Education Specialists annual meeting.
FDA clears tubeless automated insulin delivery system for adults with type 2 diabetes
The FDA has cleared an automated insulin delivery system for adults aged 18 years and older with type 2 diabetes, Insulet Corp. announced.